Cargando…

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma

BACKGROUND: Clear-cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Although ccRCC is characterized by common recurrent genetic abnormalities, including inactivation of the von Hippel-Lindau (vhl) tumor suppressor gene resulting in stabilization of hypoxia-inducible factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrosetti, Damien, Dufies, Maeva, Dadone, Bérengère, Durand, Matthieu, Borchiellini, Delphine, Amiel, Jean, Pouyssegur, Jacques, Rioux-Leclercq, Nathalie, Pages, Gilles, Burel-Vandenbos, Fanny, Mazure, Nathalie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826688/ https://www.ncbi.nlm.nih.gov/pubmed/29481555 http://dx.doi.org/10.1371/journal.pone.0193477

Ejemplares similares

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2017)

Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients
por: Fabbri, Lucilla, et al.
Publicado: (2020)

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
por: Dufies, Maeva, et al.
Publicado: (2021)

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma
por: Dufies, Maeva, et al.
Publicado: (2018)

AGAP3 : A novel BRAF fusion partner in pediatric pancreatic‐type acinar cell carcinoma
por: Paoli, Charlotte, et al.
Publicado: (2022)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
por: Dufies, Maeva, et al.
Publicado: (2017)

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5
por: Giuliano, Sandy, et al.
Publicado: (2019)

Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author’s reply
por: Burel-Vandenbos, Fanny, et al.
Publicado: (2020)

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2023)

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
por: Ndiaye, Papa Diogop, et al.
Publicado: (2019)

The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma
por: Kim, Sewha, et al.
Publicado: (2013)

MCT4 is an important determinant for the growth of highly glycolytic and aggressive malignancies
por: Unsal-Kacmaz, Kezi, et al.
Publicado: (2012)

Superficial CD34-positive Fibroblastic Tumour: Unique Subungual Presentation with Confounding Clinical Findings Resembling Fibrokeratoma-like Bowen’s Disease
por: PERRIN, Christophe, et al.
Publicado: (2021)

Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2016)

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection
por: Cardot-Leccia, Nathalie, et al.
Publicado: (2020)

Co‐culture of human fibroblasts, smooth muscle and endothelial cells promotes osteopontin induction in hypoxia
por: Sadaghianloo, Nirvana, et al.
Publicado: (2020)

SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas
por: Dufies, Maeva
Publicado: (2020)

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
por: Birsoy, Kivanc, et al.
Publicado: (2012)

Experimental Models in Neovascular Age Related Macular Degeneration
por: Rastoin, Olivia, et al.
Publicado: (2020)

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
por: Rademakers, Saskia E, et al.
Publicado: (2011)

A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment
por: Dayan, Frédéric, et al.
Publicado: (2008)

AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts
por: Pelletier, Joffrey, et al.
Publicado: (2015)

LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
por: Jing, Lun, et al.
Publicado: (2019)

GLUT1 is redundant in hypoxic and glycolytic nucleus pulposus cells of the intervertebral disc
por: Johnston, Shira N., et al.
Publicado: (2023)

Autoregulation of H(+)/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production
por: Blaszczak, Wiktoria, et al.
Publicado: (2022)

Glycogen Synthesis is Induced in Hypoxia by the Hypoxia-Inducible Factor and Promotes Cancer Cell Survival
por: Pelletier, Joffrey, et al.
Publicado: (2012)

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
por: Stewart, Paul A., et al.
Publicado: (2015)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
por: Chen, Hai‐Long, et al.
Publicado: (2018)

Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
por: Gerlinger, Marco, et al.
Publicado: (2012)

TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A
por: Koedderitzsch, Kathrin, et al.
Publicado: (2021)

Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2021)

Oxygen Tension Regulates Pancreatic β-Cell Differentiation Through Hypoxia-Inducible Factor 1α
por: Heinis, Mylène, et al.
Publicado: (2010)

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
por: Dufies, Maeva, et al.
Publicado: (2019)

Metabolic Plasiticy in Cancers—Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs
por: Ždralević, Maša, et al.
Publicado: (2017)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection—an application in metabolomics studies
por: Chardin, David, et al.
Publicado: (2021)

Nepheliosyne B, a New Polyacetylenic Acid from the New Caledonian Marine Sponge Niphates sp
por: Legrave, Nathalie, et al.
Publicado: (2013)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_do9569gjil6tsfmu5k4ift5vvr